Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Business, Policy & Funding » Business News » FDA Grants Emergency Use Authorizations for Wadsworth Center, Altru Dx Coronavirus Tests

FDA Grants Emergency Use Authorizations for Wadsworth Center, Altru Dx Coronavirus Tests

May 04, 2020
|
staff reporter

NEW YORK — The US Food and Drug Administration last week granted separate Emergency Use Authorizations (EUA) for SARS-CoV-2 assays developed by the New York State Department of Health's Wadsworth Center and Altru Diagnostics.

Wadsworth's New York SARS-CoV Microsphere Immunoassay for Antibody Detection is designed to detect human immunoglobulin G, immunoglobulin M, and immunoglobulin A antibodies against SARs-CoV-2 in serum. It runs on the Luminex FlexMap dual laser cytometer and is only authorized for use by Wadsworth.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Officially Notified

The US has sent its formal notice of withdrawal from the World Health Organization, according to the Wall Street Journal.

Starting With Bit of a Raise

Science reports that a draft spending bill would increase the US National Institutes of Health budget by 13 percent.

Harvard, MIT File Lawsuit Against Trump Administration

The Harvard Crimson reports that Harvard and MIT are suing the Department of Homeland Security and ICE over the new international student visa policy.

Nucleic Acids Research Studies on Molecular Typing, RNA-DNA Hybrids, Protein-RNA Binding Tools

In Nucleic Acids Research this week: algorithm to determine molecular sequence types and other microbial features, computational method to uncover R-loop structures, and more.

Jul
14
Featured Webinar

Development of a Metagenomics-based Pathogen-Detection Assay for SARS-CoV-2 Research

Sponsored by
Agilent

This webinar will describe a rapid metagenomics assay under development for human pathogens, including the SARS-CoV-2 coronavirus.

Jul
15
Featured Webinar

Diagnostic Challenges in Cancer Immunotherapy: An Expert Panel Discussion

Sponsored by
LGC SeraCare Life Sciences

Cancer immunotherapy is an exciting new advance for the successful treatment of many forms of metastatic cancer.

Jul
22
Featured Webinar

Advances in Genetic Testing for IVF Research: PGT-A, PGT-M, and Carrier Screening

Sponsored by
Thermo Fisher Scientific

Luis A. Alcaraz, cofounder of Bioarray and Journey Genomics, accredited diagnostic and research labs based in Alicante, Spain, will review how his teams use advanced genomic techniques for carrier screening research as well as for preimplantation genetic testing (PGT) in embryos for both aneuploidies (PGT-A) and monogenic disorders (PGT-M).

Jul
23
Featured Webinar

Clinical Utility of Liquid Biopsy for the Detection of T790M to Guide Lung Cancer Treatment Strategy

Sponsored by
Roche

This webinar will discuss a study that set to assess the efficacy and safety of osimertinib in EGFR T790M positive non-small cell lung cancer (NSCLC) patients identified by using plasma sample and cobas EGFR Mutation test v2. This is the first prospective study to use liquid biopsy upfront to evaluate osimertinib efficacy.

What's Popular?

In Molecular Diagnostics

  1. Thermo Fisher Scientific, Chugai Pharmaceutical Sign Companion Diagnostic Agreement for NSCLC

  2. FDA Issues New Guidance for SARS-CoV-2 Pooled Sample Testing

  3. Guardant Health to Develop Liquid Biopsy Companion Diagnostic for Janssen NSCLC Therapy

  4. CDC Combined COVID-19/Influenza Test Gets FDA Emergency Use Authorization

  5. FDA Letter Warns About False-Positive Results From Becton Dickinson SARS-CoV-2 Test

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.